international liver cancer congress
-
BioAlliance Pharma presents orphan drug survival results at international liver cancer congress
BioAlliance Pharma SA announces oral communication of the phase 2 clinical trial results of its orphan product Livatag at the annual congress of ILCA (International Liver Cancer Association). Prof Philippe Merle, Professor of hepatology at the Hos…
international liver cancer congress | 06 September 2011












